Search

Displaying results 7981 - 7990 of 10000 in total
  1. Drug

    Sotigalimab

    go.drugbank.com/drugs/DB16413
    Investigational

    Sotigalimab is under investigation in clinical trial NCT03123783 (CD40 Agonistic Antibody APX005M in Combination With Nivolumab).

  2. Drug

    Cadisegliatin

    go.drugbank.com/drugs/DB18886
    Investigational

    Cadisegliatin is under investigation in clinical trial NCT06334133 (Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes).

  3. Drug

    Linrodostat

    go.drugbank.com/drugs/DB14986
    Investigational

    Linrodostat is under investigation in clinical trial NCT03247283 (Pharmacokinetics and Metabolism Study in Healthy Male Participants).

  4. Drug

    iota-Carrageenan

    go.drugbank.com/drugs/DB15304
    Investigational

    iota-Carrageenan is under investigation in clinical trial NCT01944631 (Iota-Carrageenan Nasal Spray in Common Cold).

  5. Drug

    Pidilizumab

    go.drugbank.com/drugs/DB15383
    Investigational

    Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).

  6. Drug

    Ivarimod

    go.drugbank.com/drugs/DB19605
    Experimental

    Ivarimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Ivarimod is a immunomodulator, both stimulant/suppressive and stimulant.

  7. Drug

    Epertinib

    go.drugbank.com/drugs/DB20062
    Experimental

    Epertinib is a small molecule drug. The usage of the INN stem '-ertinib' in the name indicates that Epertinib is a epidermal growth factor receptor (EGFR) inhibitor.

  8. Drug

    Quiflapon

    go.drugbank.com/drugs/DB20376
    Experimental

    Quiflapon is a small molecule drug. The usage of the INN stem '-flapon' in the name indicates that Quiflapon is a 5-lipoxygenase-activating protein (FLAP) inhibitor.

  9. Drug

    Burapitant

    go.drugbank.com/drugs/DB20607
    Experimental

    Burapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1​ (substance P) receptor antagonist.

  10. Drug

    Adarigiline

    go.drugbank.com/drugs/DB21418
    Experimental

    Adarigiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Adarigiline is a monoamine oxydase (MAO)-inhibitor type B.